NCT06148532
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 2)
Enrolling by Invitation
Not specifiedAges 18+ObservationalColumbia UniversityInvestigator-initiated
~400,000 participants
Updated 2026-01-21 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Maternal sepsis risk
Measured over Delivery hospitalization through 8 weeks postpartum
Conditions
Where it's being run
1 sites across 1 statesNew York1
Study leadership
- Dena Goffman, MD · PRINCIPAL_INVESTIGATOR · Columbia University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Be 18 years or older
Delivery admission (and) postpartum readmission at one of the Perinatal Research Consortium sites 2014-2021
Exclusion
Under 18 years old
Delivery admission (and) postpartum readmission at hospital that is not in the Perinatal Research Consortium
Delivery admission before 2014 or after 2021
What this trial measures
- Maternal sepsis riskDelivery hospitalization through 8 weeks postpartum
Sepsis as evaluated by the following scoring systems: Sepsis-2 (proven or suspected infection in combination with at least two systemic inflammatory response syndrome criteria); Sepsis-3 (organ dysfunction as defined by an acute change in total organ dysfunction score within 24 hours of suspected infection); and Center for Disease Control (CDC) Sepsis (presumed infection and organ dysfunction based on CDC criteria).